Glucose-regulated stresses cause degradation of DNA topoisomerase IIα by inducing nuclear proteasome during G1 cell cycle arrest in cancer cells

Journal of Cellular Physiology

Volumn 180, Issue 1, 1999, Pages 97-104

  Kim, Hong Duck ^a   Tomida, Akihiro ^a   Ogiso, Yasunari ^a   Tsuruo, Takashi ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); GLUCOSE; PROTEASOME;

ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; COLON ADENOCARCINOMA; ENZYME DEGRADATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS;

ANTIGENS, NEOPLASM; ANTIMETABOLITES; CALCIMYCIN; CELL FRACTIONATION; CELL NUCLEUS; COLONIC NEOPLASMS; CYSTEINE ENDOPEPTIDASES; DEOXYGLUCOSE; DNA TOPOISOMERASES, TYPE II; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA-BINDING PROTEINS; G1 PHASE; GLUCOSAMINE; GLUCOSE; HT29 CELLS; HUMANS; IONOPHORES; ISOENZYMES; MITOSIS; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; STRESS; UBIQUITINS;

EID: 0033004470     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199907)180:1<97::AID-JCP11>3.0.CO;2-Y     Document Type: Article

References (42)

1. Baumeister W, Walz J, Zuhl F, Seemuller E. 1998. The proteasome: paradigm of a self-compartmentalizing protease. Cell 92:367-380.
2. Beck WT, Danks MK, Wolverton JS, Chen M, Granzen B, Kim R, Suttle DP. 1994. Resistance of mammalian tumor cells to inhibitors of DNA topoisomerase II. Adv Pharmacol 29B:145-169.
3. Bush KT, Goldberg AL, Nigam SK. 1997. Proteasome inhibition leads to a heat-shock response, induction of endoplasmic reticulum chaperones, and thermotolerance. J Biol Chem 272:9086-9092.
4. Cai JW, Henderson BW, Shen JW, Subjeck JR. 1993. Induction of glucose regulated proteins during growth of a murine tumor. J Cell Physiol 154:229-237.
5. Capranico G, Binaschi M, Borgnetto ME, Zunino F, Palumbo M. 1997. A protein-mediated mechanism for the DNA sequence-specific action of topoisomerase II poisons. Trends Pharmacol Sci 18:323-329.
6. Chen AY, Liu LF. 1994. Mechanisms of resistance to topoisomerase inhibitors. Cancer Treat Res 73:263-281.
7. Chow KC, Ross WE. 1987. Topoisomerase-specific drug sensitivity in relation to cell cycle progression. Mol Cell Biol 7:3119-3123.
8. Coux O, Tanaka K, Goldberg AL. 1996. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 65:801-847.
9. Doyle LA. 1994. Topoisomerase expression in cancer cell lines and clinical samples. Cancer Chemother Pharmacol 34:S32-40.
10. Froelich-Ammon SJ, Osheroff N. 1995. Topoisomerase poisons: harnessing the dark side of enzyme mechanism. J Biol Chem 270: 21429-21432.
11. Heck MM, Earnshaw WC. 1986. Topoisomerase II: a specific marker for cell proliferation. J Cell Biol 103:2569-2581.
12. Heck MM, Hittelman WN, Earnshaw WC. 1988. Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc Natl Acad Sci USA 85:1086-1090.
13. Hsiang YH, Wu HY, Liu LF. 1988. Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells. Cancer Res 48:3230-3235.
14. Hughes CS, Shen JW, Subjeck JR. 1989. Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells. Cancer Res 49:4452-4454.
15. Ishiura S, Nishikawa T, Tsukahara T, Momo T, Ito H, Suzuki K, Sugita H. 1990. Distribution of Alzheimer's disease amyloid A4-generating enzymes in rat brain tissue. Neurosci Lett 115:329-334.
16. Knuehl C, Seelig A, Brecht B, Henklein P, Kloetzel PM. 1996. Functional analysis of eukaryotic 20S proteasome nuclear localization signal. Exp Cell Res 225:67-74.
17. Kroll DJ, Rowe TC. 1991. Phosphorylation of DNA topoisomerase II in a human tumor cell line. J Biol Chem 266:7957-7961.
18. Lee AS. 1981. The accumulation of three specific proteins related to glucose-regulated proteins in a temperature-sensitive hamster mutant cell line K12. J Cell Physiol 106: 119-125.
19. Lee AS. 1987. Coordinated regulation of a set of genes by glucose and calcium ionophores in mammalian cells. Trends Biochem Sci 12:20-23.
20. Lee AS. 1992. Mammalian stress response: induction of the glucose-regulated protein family. Curr Opin Cell Biol 4:267-273.
21. Malonne H, Atassi G. 1997. DNA topoisomerase targeting drugs: mechanisms of action and perspectives. Anticancer Drugs 8:811-822.
22. Nakajima T, Morita K, Ohi N, Arai T, Nozaki N, Kikuchi A, Osaka F, Yamao F, Oda K. 1996. Degradation of topoisomerase IIalpha during adenovirus E1A-induced apoptosis is mediated by the activation of the ubiquitin proteolysis system. J Biol Chem 271:24842-24849.
23. Nederlof PM, Wang HR, Baumeister W. 1995. Nuclear localization signals of human and thermoplasma proteasomal alpha subunits are functional in vitro. Proc Natl Acad Sci USA 92:12060-12064.
24. Palmer A, Mason GG, Paramio JM, Knecht E, Rivett AJ. 1994. Changes in proteasome localization during the cell cycle. Eur J Cell Biol 64:163-175.
25. Palmer A, Rivett AJ, Thomson S, Hendil KB, Butcher GW, Fuertes G, Knecht E. 1996. Subpopulations of proteasomes in rat liver nuclei, microsomes and cytosol. Biochem J 316:401-407.
26. Peters JM, Franke WW, Kleinschmidt JA. 1994. Distinct 19 S and 20 S subcomplexes of the 26 S proteasome and their distribution in the nucleus and the cytoplasm. J Biol Chem 269:7709-7718.
27. Pommier Y, Leteurtre F, Fesen MR, Fujimori A, Bertrand R, Solary E, Kohlhagen G, Kohn KW. 1994. Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest 12:530-542.
28. Reits EAJ, Benham AM, Plougastel B, Neefjes J, Trowsdale J. 1997. Dynamics of proteasome distribution in living cells. EMBO J 16: 6087-6094.
29. Shen J, Hughes C, Chao C, Cai J, Bartels C, Gessner T, Subjeck J. 1987. Coinduction of glucose-regulated proteins and doxorubicin resistance in Chinese hamster cells. Proc Natl Acad Sci USA 84: 3278-3282.
30. Shen JW, Subjeck JR, Lock RB, Ross WE. 1989. Depletion of topoisomerase II in isolated nuclei during a glucose-regulated stress response. Mol Cell Biol 9:3284-3291.
31. Sullivan DM, Latham MD, Ross WE. 1987. Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells. Cancer Res 47:3973-3979.
32. Sutherland RM. 1988. Cell and environment interactions in tumor microregions: the multicell spheroid model. Science 240:177-184.
33. Tanaka K, Yoshimura T, Tamura T, Fujiwara T, Kumatori A, Ichihara A. 1990. Possible mechanism of nuclear translocation of proteasomes. FEBS Lett 271:41-46.
34. Tomida A, Suzuki H, Kim H-D, Tsuruo T. 1996a. Glucose-regulated stresses cause decreased expression of cyclin D1 and hypophosphorylation of retinoblastoma protein in human cancer cells. Oncogene 13:2699-2706.
35. Tomida A, Yun J, Tsuruo T. 1996b. Glucose-regulated stresses induce resistance to camptothecin in human cancer cells. Int J Cancer 68:391-396.
36. Tsubuki S, Kawasaki H, Saito Y, Miyashita N, Inomata M, Kawashima S. 1993. Purification and characterization of a Z-Leu-Leu-Leu-MCA degrading protease expected to regulate neurite formation: a novel catalytic activity in proteasome. Biochem Biophys Res Commun 196:1195-1201.
37. Tsubuki S, Saito Y, Tomioka M, Ito H, Kawashima S. 1996. Differential inhibition of calpain and proteasome activities by peptidyl aldehydes of di-leucine and tri-leucine. J Biochem 119:572-576.
38. Tsukabara T, Ishiura S, Sugita H. 1988. An ATP-dependent protease and ingensin, the multicatalytic proteinase, in K562 cells. Eur J Biochem 177:261-266.
39. Wang JC. 1996. DNA topoisomerases. Annu Rev Biochem 65:635-692.
40. Wang HR, Kania M, Baumeister W, Nederlof PM. 1997. Import of human and Thermoplasma 20S proteasomes into nuclei of HeLa cells requires functional NLS sequences. Eur J Cell Biol 73:105-113.
41. Wilk S, Orlowski M. 1980. Cation-sensitive neutral endopeptidase: isolation and specificity of the bovine pituitary enzyme. J Neurochem 35:1172-1182.
42. Yun J, Tomida A, Nagata K, Tsuruo T. 1995. Glucose-regulated stresses confer resistance to VP-16 in human cancer cells through a decreased expression of DNA topoisomerase II. Oncol Res 7:583-590.